Stocks and Investing Stocks and Investing
Mon, April 13, 2020

Raghuram Selvaraju Initiated (BBIO) at Strong Buy and Held Target at $50 on, Apr 13th, 2020


Published on 2024-10-27 02:43:34 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Initiated "BridgeBio Pharma, Inc." (BBIO) at Strong Buy and Held Target at $50 on, Apr 13th, 2020.

Raghuram has made no other calls on BBIO in the last 4 months.



There are 2 other peers that have a rating on BBIO. Out of the 2 peers that are also analyzing BBIO, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Raghuram


  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $43 on, Tuesday, March 3rd, 2020
  • Salim Syed of "Mizuho" Initiated at Strong Buy and Held Target at $51 on, Wednesday, February 19th, 2020
Contributing Sources